Integra LifeSciences (IART) Tops Q1 EPS by 12c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Integra LifeSciences (IART) PT Raised to $78 at BTIG
April 28, 2021 1:16 PM EDTBTIG analyst Ryan Zimmerman raised the price target on Integra LifeSciences (NASDAQ: IART) to $78.00 (from $74.00) while maintaining a Buy rating.
The analyst commented, "We maintain our Buy and raise our IART PT to $78 (from $74) following better-than-expected 1Q21 results. Rev. of $360.1M (1.6% Y/Y,... More
